PGNY
Progyny, Inc.
Latest Form 4:Sale$71KbyCummings Melissa B (Chief Operating Officer) · filed Jul 16, 2026
Progyny, Inc. (PGNY) has 50 SEC Form 4 filings (81 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Sep 1, 2026.
Inside the rolling window, 7 insiders at Progyny, Inc. reported 1 open-market purchase totaling $1.9M and 20 open-market sales totaling $1.9M. The most active filer is EVP, GC Swartz Allison with 9 filings. Insiders have net sold $1.1M over the trailing 6 months. The most recent open-market filing is a sale of 2,244 shares by Chief Operating Officer Cummings Melissa B, dated Jul 14, 2026, worth $71K.
- Industry:Medical - Healthcare Information Services
- CEO:Pete Anevski
- Employees:846
- HQ:New York City, NY, US
- IPO:2019-10-25
Insider Buying
$1.9M
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$2.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Operating Officer | Sale | 2,244 | $71K | Jul 16 | SEC ↗ | |
| EVP, GC | Sale | 1,199 | $30K | Jun 5 | SEC ↗ | |
| EVP, GC | Sale | 599 | $15K | Jun 5 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 2,517 | $64K | Jun 5 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 279 | $7K | Jun 3 | SEC ↗ | |
Scott CherylFirst filing | Director | Sale | 7,439 | $196K | Jun 3 | SEC ↗ |
Clapp GeoffreyFirst filing | Chief Product Officer | Sale | 1,530 | $39K | Jun 3 | SEC ↗ |
| EVP, GC | Sale | 2,398 | $61K | Jun 1 | SEC ↗ | |
GORDON KEVIN KFirst filing | Director | Sale | 5,500 | $137K | May 29 | SEC ↗ |
Cummings Melissa BFirst filing | Chief Operating Officer | Sale | 9,578 | $239K | May 21 | SEC ↗ |
Livingston Mark S.First in 5 months | CHIEF FINANCIAL OFFICER | Sale | 8,275 | $211K | May 21 | SEC ↗ |
| EVP, GC | Sale | 599 | $11K | Mar 6 | SEC ↗ | |
| EVP, GC | Sale | 2,199 | $38K | Mar 4 | SEC ↗ | |
| EVP, GC | Sale | 4,657 | $81K | Mar 4 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 459 | $12K | Dec 15 | SEC ↗ | |
| EVP, GC | Sale | 530 | $13K | Dec 8 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 213 | $5K | Dec 4 | SEC ↗ | |
| EVP, GC | Sale | 2,398 | $64K | Dec 2 | SEC ↗ | |
Livingston Mark S.First filing | CHIEF FINANCIAL OFFICER | Sale | 21,303 | $543K | Nov 19 | SEC ↗ |
Anevski PeterFirst filing | CHIEF EXECUTIVE OFFICER | Purchase | 79,500 | $1.9M | Nov 17 | SEC ↗ |
Swartz AllisonFirst filing | EVP, GC | Sale | 599 | $14K | Sep 5 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does PGNY have?
Progyny, Inc. (PGNY) has 50 SEC Form 4 filings (81 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Sep 1, 2026.
When was the most recent SEC Form 4 filing for PGNY?
The most recent Form 4 filing for PGNY on Tracefour is dated Sep 1, 2026.
Who is the most active insider at PGNY?
The most active SEC Form 4 filer at PGNY in the rolling window is EVP, GC Swartz Allison, with 9 filings.
What is the net insider flow at PGNY over the last 6 months?
Over the trailing 180 days, insiders at PGNY have net sold $1.1M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PGNY in the current window?
Inside the rolling window, insiders at PGNY bought $1.9M and sold $1.9M based on SEC Form 4 filings.
Can I get alerts for PGNY insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Progyny, Inc. (PGNY). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Progyny, Inc. is in the Healthcare sector.